These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19954102)

  • 1. Anemia and infections in multiple myeloma: supportive therapy.
    Cáceres W; Santiago K; Paulo L; Román J
    Bol Asoc Med P R; 2009; 101(2):50-2. PubMed ID: 19954102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia in multiple myeloma.
    Ludwig H; Pohl G; Osterborg A
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
    Barlogie B
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin and the anemia of multiple myeloma.
    Barlogie B; Beck T
    Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma.
    Dammacco F; Luccarelli G; Prete M; Silvestris F
    Rev Clin Exp Hematol; 2002; Suppl 1():32-8. PubMed ID: 12735213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies.
    Mittelman M; Zeidman A; Kanter P; Katz O; Oster H; Rund D; Neumann D
    Eur J Haematol; 2004 Mar; 72(3):155-65. PubMed ID: 14962233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythropoietin].
    Kubanek B; Rich I; Noé G
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():46-50. PubMed ID: 7531047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
    Osterbor A
    Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma.
    San Miguel JF; García-Sanz R
    Med Oncol; 1998 Aug; 15 Suppl 1():S29-34. PubMed ID: 9785334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
    Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
    Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia therapy: individual benefit and societal cost.
    Denton TA; Diamond GA; Matloff JM; Gray RJ
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):29-35. PubMed ID: 8202723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of erythropoietin in patients with multiple myeloma.
    Egerer G; Harter C; Karthaus M; Ho AD; Goldschmidt H
    Onkologie; 2003 Feb; 26(1):80-4. PubMed ID: 12624523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supportive care in multiple myeloma.
    Ludwig H; Zojer N
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):817-35. PubMed ID: 18070721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
    Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
    Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of complications in multiple myeloma.
    Terpos E; Cibeira MT; Blade J; Ludwig H
    Semin Hematol; 2009 Apr; 46(2):176-89. PubMed ID: 19389501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To give or not to give recombinant EPO to anemia endangered cancer patients.
    Sulkowska M; Wincewicz A; Chabowska A; Kanczuga-Koda L; Szymanska M; Koda M; Witkowska E; Sulkowski S
    Prague Med Rep; 2006; 107(3):281-9. PubMed ID: 17385400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.